Published in J Cancer on March 16, 2014
Special issue on current challenges and future directions in monitoring recurrence after treatment of primary cancer. J Cancer (2014) 0.75
Fine needle aspiration cytology of lymph nodes in breast cancer follow-up is a feasible alternative to watchful waiting and to histology. BMC Womens Health (2015) 0.75
Early Diagnosis of Breast Cancer. Sensors (Basel) (2017) 0.75
Molecular portraits of human breast tumours. Nature (2000) 94.14
A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med (2002) 58.15
Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med (2004) 27.92
Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer. J Clin Oncol (2006) 16.25
Diagnostic performance of digital versus film mammography for breast-cancer screening. N Engl J Med (2005) 14.47
Strategies for subtypes--dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011. Ann Oncol (2011) 13.95
Breast cancer classification and prognosis based on gene expression profiles from a population-based study. Proc Natl Acad Sci U S A (2003) 13.00
Screening for breast cancer: an update for the U.S. Preventive Services Task Force. Ann Intern Med (2009) 11.96
Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer: a validation study of the CellSearch system. Clin Cancer Res (2007) 6.59
Circulating tumor cells: a novel prognostic factor for newly diagnosed metastatic breast cancer. J Clin Oncol (2005) 6.18
Metastatic behavior of breast cancer subtypes. J Clin Oncol (2010) 6.17
Randomized trial of breast self-examination in Shanghai: final results. J Natl Cancer Inst (2002) 5.57
Breast cancer subtypes and the risk of local and regional relapse. J Clin Oncol (2010) 5.44
Swedish two-county trial: impact of mammographic screening on breast cancer mortality during 3 decades. Radiology (2011) 5.17
Circulating tumor cells at each follow-up time point during therapy of metastatic breast cancer patients predict progression-free and overall survival. Clin Cancer Res (2006) 4.95
American Society of Clinical Oncology 2006 update of the breast cancer follow-up and management guidelines in the adjuvant setting. J Clin Oncol (2006) 4.61
Circulating tumour cells in non-metastatic breast cancer: a prospective study. Lancet Oncol (2012) 4.44
A population-based study of tumor gene expression and risk of breast cancer death among lymph node-negative patients. Breast Cancer Res (2006) 4.28
Bone imaging in metastatic breast cancer. J Clin Oncol (2004) 3.85
Biodistribution of 89Zr-trastuzumab and PET imaging of HER2-positive lesions in patients with metastatic breast cancer. Clin Pharmacol Ther (2010) 3.42
A minimalist policy for breast cancer surveillance. JAMA (1991) 3.08
Assessing the future of diffuse optical imaging technologies for breast cancer management. Med Phys (2008) 3.02
A clinical development paradigm for cancer vaccines and related biologics. J Immunother (2007) 2.97
NCCN clinical practice guidelines in oncology: breast cancer screening and diagnosis. J Natl Compr Canc Netw (2009) 2.78
Imaging in breast cancer: diffuse optics in breast cancer: detecting tumors in pre-menopausal women and monitoring neoadjuvant chemotherapy. Breast Cancer Res (2005) 2.68
Breast cancer follow-up and management after primary treatment: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol (2012) 2.62
Use of statistics to assess the global burden of breast cancer. Breast J (2006) 2.56
Selectivity of 18F-FLT and 18F-FDG for differentiating tumor from inflammation in a rodent model. J Nucl Med (2004) 2.22
Metabolic flare: indicator of hormone responsiveness in advanced breast cancer. J Clin Oncol (2001) 2.20
Circulating tumor cell detection predicts early metastatic relapse after neoadjuvant chemotherapy in large operable and locally advanced breast cancer in a phase II randomized trial. Clin Cancer Res (2008) 2.16
Assessing radiologist performance using combined digital mammography and breast tomosynthesis compared with digital mammography alone: results of a multicenter, multireader trial. Radiology (2012) 2.14
Quantitative fluoroestradiol positron emission tomography imaging predicts response to endocrine treatment in breast cancer. J Clin Oncol (2006) 2.12
Changing pattern of the detection of locoregional relapse in breast cancer: the Edinburgh experience. Br J Cancer (2007) 2.07
The 70-gene prognosis-signature predicts disease outcome in breast cancer patients with 1-3 positive lymph nodes in an independent validation study. Breast Cancer Res Treat (2008) 1.96
Diffuse optical imaging of the healthy and diseased breast: a systematic review. Breast Cancer Res Treat (2007) 1.93
HER2-positive circulating tumor cells indicate poor clinical outcome in stage I to III breast cancer patients. Clin Cancer Res (2006) 1.93
AN OVERVIEW OF ELASTOGRAPHY - AN EMERGING BRANCH OF MEDICAL IMAGING. Curr Med Imaging Rev (2011) 1.73
PET-based estradiol challenge as a predictive biomarker of response to endocrine therapy in women with estrogen-receptor-positive breast cancer. Breast Cancer Res Treat (2008) 1.72
Isolation and characterization of circulating tumor cells in patients with metastatic colorectal cancer. Clin Colorectal Cancer (2006) 1.72
Clinical significance of immunocytochemical detection of tumor cells using digital microscopy in peripheral blood and bone marrow of breast cancer patients. Clin Cancer Res (2004) 1.68
Tactile imaging of breast masses: first clinical report. Arch Surg (2001) 1.68
Beyond mammography: new frontiers in breast cancer screening. Am J Med (2013) 1.61
Different prognostic value of cytokeratin-19 mRNA positive circulating tumor cells according to estrogen receptor and HER2 status in early-stage breast cancer. J Clin Oncol (2007) 1.60
Quantitative imaging of estrogen receptor expression in breast cancer with PET and 18F-fluoroestradiol. J Nucl Med (2008) 1.57
Intraoperative ultrasound facilitates surgery for early breast cancer. Ann Surg Oncol (2002) 1.56
Second malignancies after treatment of early-stage breast cancer: lumpectomy and radiation therapy versus mastectomy. J Clin Oncol (2000) 1.54
Popularity of less frequent follow up for breast cancer in randomised study: initial findings from the hotline study. BMJ (1997) 1.54
Real-time RT-PCR detection of disseminated tumour cells in bone marrow has superior prognostic significance in comparison with circulating tumour cells in patients with breast cancer. Br J Cancer (2006) 1.46
Follow-up in breast cancer: does routine clinical examination improve outcome? A systematic review of the literature. Br J Cancer (2007) 1.36
Digital breast tomosynthesis in the diagnostic environment: A subjective side-by-side review. AJR Am J Roentgenol (2010) 1.34
Comparison of the clinical significance of occult tumor cells in blood and bone marrow in breast cancer. Int J Cancer (2006) 1.33
The molecular profile of luminal B breast cancer. Biologics (2012) 1.33
Impact on survival of early detection of isolated breast recurrences after the primary treatment for breast cancer: a meta-analysis. Breast Cancer Res Treat (2008) 1.30
Detection of breast cancer cells in the peripheral blood is positively correlated with estrogen-receptor status and predicts for poor prognosis. Int J Cancer (2003) 1.28
Meta-analysis of quantitative diffusion-weighted MR imaging in the differential diagnosis of breast lesions. BMC Cancer (2010) 1.26
Digital breast tomosynthesis versus supplemental diagnostic mammographic views for evaluation of noncalcified breast lesions. Radiology (2012) 1.25
Radiation risk from screening mammography of women aged 40-49 years. J Natl Cancer Inst Monogr (1997) 1.25
Digital breast tomosynthesis (DBT): initial experience in a clinical setting. Acta Radiol (2012) 1.24
Detection of cytokeratin-19 mRNA-positive cells in the peripheral blood and bone marrow of patients with operable breast cancer. Br J Cancer (2009) 1.24
Prognostic impact of circulating tumor cells assessed with the CellSearch System™ and AdnaTest Breast™ in metastatic breast cancer patients: the DETECT study. Breast Cancer Res (2012) 1.21
Mammography screening for breast cancer: a view from 2 worlds. JAMA (2010) 1.15
Circulating tumor cells: detection, molecular profiling and future prospects. Expert Rev Proteomics (2007) 1.11
Can diffusion-weighted MR imaging and contrast-enhanced MR imaging precisely evaluate and predict pathological response to neoadjuvant chemotherapy in patients with breast cancer? Breast Cancer Res Treat (2012) 1.10
Improving clinical breast examination training in a medical school: a randomized controlled trial. J Gen Intern Med (1993) 1.10
Micrometastatic spread in breast cancer: detection, molecular characterization and clinical relevance. Breast Cancer Res (2008) 1.09
Breast cancer recurrence diagnosis suspected on tumor marker rising: value of whole-body 18FDG-PET/CT imaging and impact on patient management. Cancer (2010) 1.01
Contrast enhanced mammography: techniques, current results, and potential indications. Clin Radiol (2013) 0.95
Improving physicians' and nurses' clinical breast examination: a randomized controlled trial. Am J Prev Med (1991) 0.95
Small-animal PET of steroid hormone receptors predicts tumor response to endocrine therapy using a preclinical model of breast cancer. J Nucl Med (2012) 0.94
Prospective study of electrical impedance scanning for identifying young women at risk for breast cancer. Breast Cancer Res Treat (2006) 0.93
Breast ultrasonography: state of the art. Radiology (2013) 0.93
Diffusion-weighted MRI in pretreatment prediction of response to neoadjuvant chemotherapy in patients with breast cancer. Eur Radiol (2013) 0.92
Assessment of progesterone receptors in breast carcinoma by PET with 21-18F-fluoro-16α,17α-[(R)-(1'-α-furylmethylidene)dioxy]-19-norpregn-4-ene-3,20-dione. J Nucl Med (2012) 0.92
Diffusion weighted magnetic resonance imaging of the breast: protocol optimization, interpretation, and clinical applications. Magn Reson Imaging Clin N Am (2013) 0.91
Magnetic resonance spectroscopy of the breast: current status. Magn Reson Imaging Clin N Am (2013) 0.91
How to optimize breast ultrasound. Eur J Radiol (2008) 0.89
Electrical impedance scanning as a new breast cancer risk stratification tool for young women. J Surg Oncol (2008) 0.88
Follow-up cost of breast cancer patients with localized disease after primary treatment: a randomized trial. Breast Cancer Res Treat (2005) 0.88
An increase in cell number at completion of therapy may develop as an indicator of early relapse: quantification of circulating epithelial tumor cells (CETC) for monitoring of adjuvant therapy in breast cancer. J Cancer Res Clin Oncol (2007) 0.87
Detection and description of small breast masses by residents trained using a standardized clinical breast exam curriculum. J Gen Intern Med (2007) 0.85
Tailored breast cancer screening program with microdose mammography, US, and MR Imaging: short-term results of a pilot study in 40-49-year-old women. Radiology (2013) 0.84
Lump detection is enhanced in silicone breast models simulating postmenopausal breast tissue. J Gen Intern Med (1996) 0.82
Effect of breast-tissue characteristics on the outcome of clinical breast examination training. Acad Med (1996) 0.82
Breast tumor detection using piezoelectric fingers: first clinical report. J Am Coll Surg (2013) 0.82
Imaging the breast with EIS: an initial study of exam consistency. Physiol Meas (2002) 0.81
Office-based and intraoperative ultrasound enhance surgeon's care of breast disease patients. Ann Surg Oncol (2003) 0.80
Breast cancer follow-up in the adjuvant setting. Curr Oncol Rep (2008) 0.79
Breast ultrasound in office gynecology--ten years of experience. Ultraschall Med (2010) 0.78
[Circulating tumor cells and breast cancer: detection techniques and clinical results]. Bull Cancer (2009) 0.78
Gene expression profiling in breast cancer. Am J Transl Res (2013) 0.77
Evaluation of office ultrasound usage among Australian and New Zealand breast surgeons. World J Surg (2013) 0.77
Economic evaluation of diagnostic follow-up after primary treatment for breast cancer. Results of the Working Group on Economic-Organizational Aspects of Follow-up. Ann Oncol (1995) 0.76
A novel robotic tactile mass detector with application in clinical breast examination. Minim Invasive Ther Allied Technol (2011) 0.76
The ability of trained nurses to detect lumps in a test set of silicone breast models. Cancer (1999) 0.75
Current approaches and challenges in monitoring treatment responses in breast cancer. J Cancer (2014) 1.13
Current approaches and challenges in early detection of breast cancer recurrence. J Cancer (2014) 1.00